Terms: = Brain cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
4049 results:
1. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
[TBL] [Abstract] [Full Text] [Related]
2. Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling.
Zheng P; Zhang X; Ren D; Bai Q
Neurol India; 2024 Mar; 72(2):297-303. PubMed ID: 38691473
[TBL] [Abstract] [Full Text] [Related]
3. Multi-Omics Pan-cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
[TBL] [Abstract] [Full Text] [Related]
4. Synthesis and Validation of TRIFAPYs as a Family of Transfection Agents for Therapeutic Oligonucleotides.
Isanta B; Delgado A; Ciudad CJ; Busquets MA; Griera R; Llor N; Noé V
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672408
[TBL] [Abstract] [Full Text] [Related]
5. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract] [Full Text] [Related]
6. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
7. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
8. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
9. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas.
Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK
Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567
[TBL] [Abstract] [Full Text] [Related]
10. [Fully Automatic Glioma Segmentation Algorithm of Magnetic Resonance Imaging Based on 3D-UNet With More Global Contextual Feature Extraction: An Improvement on Insufficient Extraction of Global Features].
Tian H; Wang Y; Ji Y; Rahman MM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):447-454. PubMed ID: 38645864
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.
Shen S; Li C; Fan Y; Lu S; Yan Z; Liu H; Zhou H; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):58-67. PubMed ID: 38615167
[TBL] [Abstract] [Full Text] [Related]
12. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
[TBL] [Abstract] [Full Text] [Related]
13. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
Marallano VJ; Ughetta ME; Tejero R; Nanda S; Ramalingam R; Stalbow L; Sattiraju A; Huang Y; Ramakrishnan A; Shen L; Wojcinski A; Kesari S; Zou H; Tsankov AM; Friedel RH
Sci Rep; 2024 Mar; 14(1):7246. PubMed ID: 38538643
[TBL] [Abstract] [Full Text] [Related]
15. Generative adversarial network-based synthesis of contrast-enhanced MR images from precontrast images for predicting histological characteristics in breast cancer.
Fan M; Cao X; Lü F; Xie S; Yu Z; Chen Y; Lü Z; Li L
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537294
[No Abstract] [Full Text] [Related]
16. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
17. Dual path parallel hierarchical diagnosis model for intracranial tumors based on multi-feature entropy weight.
Fang L; Jiang Y
Comput Biol Med; 2024 May; 173():108353. PubMed ID: 38520918
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of Conformationally Constrained ALK2 Inhibitors.
González-Álvarez H; Ensan D; Xin T; Wong JF; Zepeda-Velázquez CA; Cros J; Sweeney MN; Hoffer L; Kiyota T; Wilson BJ; Aman A; Roberts O; Isaac MB; Bullock AN; Smil D; Al-Awar R
J Med Chem; 2024 Mar; 67(6):4707-4725. PubMed ID: 38498998
[TBL] [Abstract] [Full Text] [Related]
19. Diffusion-weighted imaging-based radiomics model using automatic machine learning to differentiate cerebral cystic metastases from brain abscesses.
Cui L; Qin Z; Sun S; Feng W; Hou M; Yu D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):132. PubMed ID: 38492096
[TBL] [Abstract] [Full Text] [Related]
20. Single-cell transcriptome analysis upon ECM-remodeling meningioma cells.
Che WQ; Wang YJ; Yang L; Wang HQ; Wang XY; Lyu J
Neurosurg Rev; 2024 Mar; 47(1):118. PubMed ID: 38491247
[TBL] [Abstract] [Full Text] [Related]
[Next]
